SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IMNR - Immune Response

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Texas77 who wrote (1021)8/11/1998 6:03:00 PM
From: John S. Baker  Read Replies (1) of 1510
 
I agree with Jake that today's price is a pretty fair one. And his point ... posted here before ... that IMNR is not a single-product company; rather it has a number of projects in the fire, which results in multiple opportunities for real news even before the FDA approval of Remune.


I already have all the IMNR that my "balanced investment portfolio" can handle, but I am always happy to gobble up a few more shares for trading purposes. FWIW, my TA sez I am on the verge of doing so ... but not today or tomorrow. Will advise.


JSb.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext